Steve Bonn is a seasoned professional in regulatory affairs with extensive experience in managing operations across several leading pharmaceutical companies. Currently serving as Director of Regulatory Affairs Operations at Kura Oncology, Inc., Steve has previously held significant roles at Rocket Pharmaceuticals and NOVAVAX INC. Notable contributions include driving the conversion to electronic submissions at Baxter International Inc., where various processes for eCTD compliance were successfully implemented. Steve possesses a B.A. in Neuroscience, Biology, and Spanish from Carthage College and holds a Regulatory Affairs Certification (RAC) for Drugs in the EU and US.